Starling Oncology (STLN) Financials: Revenue & Earnings

STLN price $6.74 +0.15 +2.24%

Ticker
STLN
Price
$6.74
Change
+0.15 +2.24%
Market cap ?
$673.62M
Beta ?
0.42
Sector
Healthcare
Industry
Medical - Care Facilities

Fair value

STLN fair value $3.52. Price $6.74. Price is 91% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare STLN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-08-06-0.08-0.06161.28M155.74M
2026-05-07-0.02-0.09147.44M142.10M
2025-08-13-0.15-0.12119.80M113.32M
2025-05-14-0.21—104.41M—
2024-08-13-0.17-0.0998.60M103.31M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-21Hively BradSell298.85K$6.511.95M
2026-08-14Chernett JoreyBuy12.00K$6.5478.48K
2026-08-13Chernett JoreySell100$9.00900

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Starling Oncology, Inc. (STLN) trades at $6.74, with a market cap of $673.62M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Starling Oncology (STLN) Financials: Revenue & Earnings

STLN$6.74+0.15 +2.24%

$673.62M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History